By renubresearch Global Autoimmune Disease Diagnostics Market Overview
Market Size & Growth Forecast
- Expected to reach US$ 10.63 billion by 2033, up from US$ 5.70 billion in 2024.
- CAGR of 7.17% (2025-2033).
Download Sample:https://www.renub.com/request-sample-page.php?gturl=autoimmune-disease-diagnostic-market-p.php
Key Market Drivers
- Rising Prevalence of Autoimmune Diseases
- 2.8 million multiple sclerosis cases worldwide (2020).
- 18 million rheumatoid arthritis patients globally (2019).
- Advancements in Diagnostic Technologies
- Use of PCR, immunofluorescence, and ELISA improving diagnostic accuracy.
- Biomarker discovery enabling personalized diagnostics.
- Increasing Awareness & Early Diagnosis
- Campaigns like Autoimmune Disease Awareness Month promote screening.
- Strategic Industry Collaborations
- AbbVie acquired Landos Biopharma for autoimmune drug development.
- ScipherMedicine acquired CrossBridge to enhance data analytics in diagnostics.
Challenges in the Market
High Costs & Complexity – Advanced diagnostic equipment is expensive.
Limited Access in Developing Countries – Lack of trained professionals & diagnostic infrastructure.
Competitive Pricing Pressures – Local manufacturers offer low-cost alternatives.
Regional Market Insights
North America (United States & Canada)
- Growth driven by high disease prevalence and advanced diagnostic technologies.
- Adoption of biomarker-based diagnostics & personalized medicine.
Europe (Germany, UK, France, etc.)
- Germany’s market benefits from precision medicine & genetic testing.
- High awareness and accessibility to advanced diagnostic tools.
Asia-Pacific (China, India, Japan, Australia, etc.)
- Rising autoimmune disease cases fueling demand for high-throughput screening & molecular testing.
Middle East & Africa (UAE, Saudi Arabia, South Africa)
- Investments in PCR, ELISA, and next-generation sequencing (NGS) expanding diagnostic capabilities.
Market Segmentation
- By Product
- Diagnostics Equipment leads the market due to AI-driven automation.
- By Disease Type
- Systemic Autoimmune Diseases (Rheumatic, Lupus, etc.) dominate the market.
- By End-User
- Diagnostic Centers hold the largest market share due to cost-effectiveness and advanced testing capabilities.
Leading Market Players
- Abbott Laboratories
- Bio-Rad Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Quest Diagnostics
- Thermo Fisher Scientific
gdgoenkahealth 
jaamessmith